Related Experiment Videos
Protection from lethal irradiation by the combination of stem cell factor and tempol
J Liebmann1, A M DeLuca, A Epstein
1Radiobiology Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
Radiation Research
|March 1, 1994
Summary
Combining stem cell factor (SCF) with the nitroxide tempol significantly enhances radioprotection in mice. This combination offers greater protection against ionizing radiation than either agent alone, improving survival rates.
Area of Science:
- Hematology
- Radiation Biology
- Pharmacology
Background:
- Hematopoietic growth factors like stem cell factor (SCF) are known radioprotectors.
- The nitroxide tempol has recently demonstrated in vivo radioprotective capabilities.
- Investigating combined therapeutic strategies is crucial for improving radiation protection.
Purpose of the Study:
- To evaluate the synergistic radioprotective effects of combining stem cell factor (SCF) and tempol.
- To compare the efficacy of the SCF-tempol combination against individual treatments in mice exposed to ionizing radiation.
Main Methods:
- C57 mice were subjected to whole-body irradiation at various doses.
- Mice received treatments of SCF, tempol, or a combination of both before and after irradiation.
- Survival rates were assessed at 30 days post-irradiation to determine radioprotective efficacy.
Main Results:
- SCF alone (100 µg/kg) provided 76% survival at 10 Gy, while tempol (350 mg/kg) offered 55% survival at 9 Gy.
- The combination of SCF and tempol significantly increased survival to 32% at 11 Gy (P < 0.001).
- Lower doses of SCF and tempol, ineffective alone, provided protection when combined at 10 Gy.
Conclusions:
- Stem cell factor (SCF) and tempol act as effective radioprotectors.
- The combination of SCF and tempol demonstrates a synergistic, more than additive, radioprotective effect.
- Combined SCF and tempol therapy represents a promising strategy for mitigating radiation-induced damage.